NUCLEIN
Nuclein is a biotechnology company that develops the Hand-Held Polymerase Chain Reaction test device for infectious diseases. The test device is a disposable, all-in-one, self-testing device for infectious disease diagnosis that does not require any technical expertise and provides battery-powered, sample-to-answer results in under one hour, without the need to mail in a sample.
NUCLEIN
Industry:
Biotechnology Health Care Medical Medical Device
Founded:
2017-01-01
Address:
Austin, Texas, United States
Country:
United States
Website Url:
http://www.nuclein.com
Total Employee:
11+
Status:
Active
Total Funding:
20 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics
Similar Organizations
Immuno Technologies
Immuno Technologies is a US-based company that focuses on applied research for infectious diseases.
Lazurite
Lazurite is a biotechnology company that creates the operating room of the future through smart surgical tools.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
ORIG3N
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
Q32 Bio
Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Torus Biosystems
Torus Biosystems is a biotech startup that delivers molecular diagnostics for infectious diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Trinity Private Equity Group
Trinity Private Equity Group investment in Series B - Nuclein
Official Site Inspections
http://www.nuclein.com
- Host name: 104.21.81.56
- IP address: 104.21.81.56
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Nuclein"
Nuclein - Crunchbase Company Profile & Funding
Nuclein is a biotechnology company that develops the Hand-Held Polymerase Chain Reaction test device for infectious diseases. The test device is a disposable, all-in-one, self-testing device for infectious disease diagnosis that …See details»
Nuclein DASH Rapid PCR System
DASH™ Rapid PCR System is a simple, affordable, point-of-care platform that performs sample-to-answer PCR in 15 minutes.See details»
Team - Nuclein DASH Rapid PCR System
Nuclein, LLC was founded in 2017 by experienced biotechnology entrepreneurs Alan Blake and Dr. Richard Crockett. The company’s mission has been to enable simple, affordable, rapid, and accurate testing for everyone.See details»
Nuclein Company Profile 2024: Valuation, Funding & Investors
Developer of a real-time polymerase chain reaction system designed to provide results quickly.See details»
Nuclein - Funding, Financials, Valuation & Investors - Crunchbase
Nuclein is a biotechnology company that develops the polymerase chain reaction test device for infectious diseases.See details»
Nuclein Company Profile - Office Locations, Competitors ... - Craft
See insights on Nuclein including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Technology - Nuclein DASH Rapid PCR System
Quantitative PCR and reverse transcription, real-time PCR (RT-qPCR) Intuitive user interface with only 1 minute of actual hands on time. DASH™ is a sample-to-answer quantitative PCR system that is designed to automatically identify viral …See details»
Nuclein - Contacts, Employees, Board Members, Advisors & Alumni
Nuclein is a biotechnology company that develops the polymerase chain reaction test device for infectious diseases.See details»
Nuclein Closes $14M in Funding led by Trinity Private …
AUSTIN, Texas, March 25, 2021 /PRNewswire/ -- Nuclein, LLC has closed a $14 million Series B funding round. The financing helps Nuclein, a medical device company, to commercialize its novel,...See details»
Austin startup Nuclein raises $14M for simple Covid …
Mar 25, 2021 · Nuclein, which has now raised about $20 million total, plans to use the new funds to expand its team, find a new office space and get its cornerstone testing device through the Food and Drug ...See details»
NUCLEIN CLOSES $14M IN FUNDING LED BY TRINITY …
AUSTIN, Texas, March 25, 2021 /PRNewswire/ -- Nuclein, LLC has closed a $14 million Series B funding round. The financing helps Nuclein, a medical device company, to commercialize its novel, hand-held PCR platform designed as a …See details»
Huiping Zhu - Vice President, Assay Development at Nuclein - The …
Huiping currently serves as a Board Member for the To Cure A Rose Foundation since March 2023. Prior to that, they held roles at Nuclein, where they were the Vice President of Assay …See details»
Nucleic acid - Wikipedia
Nucleic acids are chemical compounds that are found in nature. They carry information in cells and make up genetic material. These acids are very common in all living things, where they …See details»
Friedrich Miescher and the discovery of DNA - ScienceDirect
Feb 15, 2005 · Over the past 60 years, DNA has risen from being an obscure molecule with presumed accessory or structural functions inside the nucleus to the icon of modern …See details»
DNA translated: Friedrich Miescher's discovery of nuclein in its ...
In 1871, the Swiss physiological chemist Friedrich Miescher published the results of a detailed chemical analysis of pus cells, in which he showed that the nuclei of these cells contained a …See details»
From Nuclein to the Double Helix - Science Delivered
Sep 3, 2018 · DNA holds the key to all life as we know it. From the smallest bacterium to the massive blue whale, deoxyribonucleic acid encodes the vast complexity of life through the …See details»
DNA translated: Friedrich Miescher's discovery of nuclein in its ...
Feb 19, 2021 · In 1871, the Swiss physiological chemist Friedrich Miescher published the results of a detailed chemical analysis of pus cells, in which he showed that the nuclei of these cells …See details»
Chromatin history: our view from the bridge - Nature
Oct 1, 2003 · Thirty years ago, our conception of chromatin structure underwent a total metamorphosis as the nucleosome era began. In Kurosawa's classic movie 'Rashomon' …See details»
Discovery of DNA Structure and Function: Watson and Crick
Although few people realize it, 1869 was a landmark year in genetic research, because it was the year in which Swiss physiological chemist Friedrich Miescher first identified what he called...See details»
1869: DNA First Isolated - National Human Genome Research …
Apr 22, 2013 · Miescher isolated a material rich in phosphorus from the cells and called it nuclein. He found nuclein in other types of cells as well, including salmon sperm. In the early 1900s, …See details»